Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danilo Perrotti

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Cancer Cell|April 14, 2010
Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemiaShujun Liu, Lai-Chu Wu, Jiuxia Pang, et al.
Journal of Hematology & Oncology|August 10, 2021
Treatment-induced arteriolar revascularization and miR-126 enhancement in bone marrow niche protect leukemic stem cells in AMLBin Zhang, Le Xuan Truong Nguyen, Dandan Zhao, et al.
The Journal of Clinical Investigation|March 5, 2014
SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcomeHouda Alachkar, Ramasamy Santhanam, Kati Maharry, et al.
Nature Medicine|March 6, 2018
Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemiaBin Zhang, Le Xuan Truong Nguyen, Ling Li, et al.
Nature Communications|September 1, 2023
Acquired miR-142 deficit in leukemic stem cells suffices to drive chronic myeloid leukemia into blast crisisBin Zhang, Dandan Zhao, Fang Chen, et al.
Blood Cancer Discovery|September 25, 2020
Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on <i>MIR300</i> Antiproliferative and PP2A-Activating FunctionsGiovannino Silvestri, Rossana Trotta, Lorenzo Stramucci, et al.
The Journal of Clinical Investigation|September 4, 2013
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cellsPaolo Neviani, Jason G Harb, Joshua J Oaks, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Cancer Cell|April 14, 2010
Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemiaShujun Liu, Lai-Chu Wu, Jiuxia Pang, et al.
Journal of Hematology & Oncology|August 10, 2021
Treatment-induced arteriolar revascularization and miR-126 enhancement in bone marrow niche protect leukemic stem cells in AMLBin Zhang, Le Xuan Truong Nguyen, Dandan Zhao, et al.
The Journal of Clinical Investigation|March 5, 2014
SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcomeHouda Alachkar, Ramasamy Santhanam, Kati Maharry, et al.
Nature Medicine|March 6, 2018
Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemiaBin Zhang, Le Xuan Truong Nguyen, Ling Li, et al.
Nature Communications|September 1, 2023
Acquired miR-142 deficit in leukemic stem cells suffices to drive chronic myeloid leukemia into blast crisisBin Zhang, Dandan Zhao, Fang Chen, et al.
Blood Cancer Discovery|September 25, 2020
Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on <i>MIR300</i> Antiproliferative and PP2A-Activating FunctionsGiovannino Silvestri, Rossana Trotta, Lorenzo Stramucci, et al.
The Journal of Clinical Investigation|September 4, 2013
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cellsPaolo Neviani, Jason G Harb, Joshua J Oaks, et al.
Pageof 9